drugset / Trial / NCT01131897

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

NCT01131897

Phase 1 Completed 24 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the single-dose relative bioavailability study of Levetiracetam Tablets 750 mg with Keppra® 750 mg Tablets under Fasting conditions.

Timeline

Start
2003-09
Primary completion
2003-09
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 750 mg

Indications

No indication recorded.